Please assess the completion status of the following clinical trial:

Trial Title: Safety and Effectiveness of a Computer-Assisted Personalized Sedation (CAPS) Device for Propofol Delivery During Endoscopy

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: SCREENING
- Time Perspective: None
- Masking: NONE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* ≥ 18 years old~* Able to comprehend, sign, and date the written informed consent form~* English as primary language~* Undergoing a non-emergent EGD or colonoscopy~* Have taken nothing by mouth for a minimum of 6 hours prior to the study procedure~* American Society of Anesthesiologists (ASA) Class I, II or III~Exclusion Criteria:~* Allergy or inability to tolerate study medications or components of study medications~* Investigator anticipates greater than 45 minute procedure time due to known anatomical difficulty~* Currently using a fentanyl patch~* History of diagnosed sleep apnea~* History of diagnosed gastroparesis~* Baseline oxygen saturation \< 90% (room air)~* Pregnant or nursing females~* Body mass index (BMI) ≥ 35~* Participation in a clinical trial within the past 30 days.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Sedation System (Type: EXPERIMENTAL): Computer-Assisted Personalized Sedation (CAPS) device used for delivery of sedation
- Current Standard of Care (Type: ACTIVE_COMPARATOR): Site's current standard used for delivery of sedation

Based on this trial design, predict the completion outcome and termination type (if applicable).